Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 4 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

0
Player Avatar Hazet808T5 (28.12) Submitted: 6/28/2007 4:12:34 PM : Outperform Start Price: $42.54 LGND Score: -61.90

http://valueplays.blogspot.com/2007/06/this-weeks-insider-buys.html

Featured Broker Partners


Advertisement